Table of Contents Table of Contents
Previous Page  144 / 152 Next Page
Information
Show Menu
Previous Page 144 / 152 Next Page
Page Background

S140

Abstracts / Journal of Clinical Virology 82S (2016) S1–S142

Abstract no: 218

Presentation at ESCV 2016: Poster 242

High frequency of JC human polyomavirus in

Portuguese wastewaters: A possible source for

human infection

F. Rodrigues

1 ,

, D. Gonc¸ alves

1

, C. Luxo

2

,

A.M. Matos

2

1

Laboratório de Virologia, Grupo das Biociências

Clínicas e Aplicadas, Faculdade de Farmácia da

Universidade de Coimbra, Portugal

2

Laboratório de Virologia, Grupo das Biociências

Clínicas e Aplicadas, Faculdade de Farmácia da

Universidade de Coimbra, Centro de Investigac¸ ão em

Engenharia dos Processos Químicos e dos Produtos

da Floresta (CIEPQF), Coimbra, Portugal

Introduction:

JC polyomavirus (JCV) is ubiquitous among the

human population worldwide. Primary infection, typically asymp-

tomatic, normally occurs during childhood and is followed by a

lifelong persistent infection. JCV is excreted in the urine of nearly

half of the infected individuals, without any associated clinical

symptom. Under situations of severe immunosuppression, JCVmay

reactivate and induces a rare but fatal demyelinating disease of the

central nervous system known as Progressive Multifocal Leukoen-

cephalopathy (PML). Despite several hypothesis have been raised,

the main mode of transmission remains unknown. The high fre-

quency of urinary excretion of JCV lead several authors to evaluate

its presence in sewage wastewater systems, though, to date no data

have been reported for Portuguese wastewaters. In this order, the

present study represents the first comprehensive assessment of

JCV in Portuguese wastewaters along with its removal efficiency

by wastewater treatment plants (WWTPs), in order to add further

information for a possible way of JCV transmission to occur.

Materials and methods:

Fifteen WWTP distributed all across

Portugal and serving 26.3% of theNational populationwere selected

for the present study. Two pairs of influent (WWI) (untreated)

and effluent (WWE) (treated) samples, were collected from each

WWTP, in September and December 2013, making a total of 60

wastewater samples. Viruses were concentrated by ultracentrifu-

gation as previously described

[1] , a

nd detection and quantification

of JCV DNA in wastewater samples was obtained by a quantitative

real-time PCR protocol using a set of four amplification primers and

two internal TaqMan probes, previously described

[2] .

Results:

JCV genome was detected in 14 (93%) of the 15 eval-

uated WWTP, in at least one of the collected samples. Ninety per

cent of the tested influent samples revealed detectable JCV DNA,

at relatively high concentrations (mean = 5.48

±

0.74 log10 GC/L).

The treatment of wastewater was able to completely remove JCV

genome from 14 (52%) of the 27 initial positive assessedWWI sam-

ples. In the remaining 13 initially positive WWI samples, despite

no complete removal was accomplished, a decrease in JCV concen-

tration was observed in the majority of cases.

Discussion:

The ubiquity of JCV infection, claims for a common

route of transmission, particularly when seroepidemiological sur-

veys point to childhood as the age for first infection to occur. The

present study reveals the consistent detection of JCV genome in

sewage from the different regions of Portugal. Moreover, nearly

half of the WWTP were not able to completely remove the virus,

which, by this manner will end up incorporating treated sewage

and be distributed to the surrounding environment. Such viruses

may finally contaminate food and water, which may act as vehicles

for JCV transmission through oral route.

Reference

[1] A. Rafique, S.C. Jiang, Genetic diversity of human polyomavirus JCPyV in

Southern California wastewater, J. Water Health (2008),

http:// dx. doi.o rg/1 0. 2166/ wh.2 008. 067

.

[2] C.F. Ryschkewitsch, P.N. Jensen, E.O. Major, Multiplex qPCR assay for ultra

sensitive detection of JCV DNA with simultaneous identification of genotypes

that discriminates non-virulent from virulent variants, J. Clin. Virol. 57 (2013)

243–248,

http:// dx.d oi. org/1 0.1 016/ j. jcv.2 013. 03.0 09 . http://dx.doi.org/10.1016/j.jcv.2016.08.282

Abstract no: 282

Presentation at ESCV 2016: Poster 243

An unusual course of parvovirus B19 infection,

strongly suggestive of virus reactivation

U. Reber

1 ,

, S. Aldabbagh

1

, S. Pietzonka

1

,

O. Moser

2 , 3

, A. Simon

2 , 4

, D. Dilloo

2

,

A. Eis-Hübinger

1

1

Institute of Virology, University of Bonn Medical

Center, Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn,

Germany

2

Department of Pediatric Hematology and Oncology,

Center for Pediatrics, University of Bonn Medical

Center, Bonn, Germany

3

Division of Pediatric Hematology, Oncology & Stem

Cell Transplantation, University of Aachen, Germany

4

Pediatric Oncology and Hematology, Children’s

University Hospital, Homburg, Saar, Germany

Because of its highly efficient replication in erythroid progenitor

cells, parvovirus B19 (B19V) causes an interruption of the red cell

production which may result in a more or less severe anemia. After

primary infection and elimination of viremia, viral DNA persists

at low levels in multiple tissues, probably for life. It is not clear

whether the persisting virus is able to reactivate.

We present a case of severe B19V infection in a patient with

spherocytosis that was followed by a further episode of severe

anemia with B19V viremia three years later. Nearly full-length

nucleotide sequencing of the B19V genomes detected in blood

during primary infection and after three years revealed complete

identity of the genomes. Although not apodictically proven, this

case demonstrates that, in rare instances, recurrence of B19V infec-

tion might be possible.

http://dx.doi.org/10.1016/j.jcv.2016.08.283

Abstract no: 343

Presentation at ESCV 2016: Poster 244

Parvovirus B19: Its real disease associations

A.C.M. Kroes

Leiden University Medical Center, The Netherlands

Parvovirus B19 (B19V or primate erythroparvovirus 1, ssDNA)

is dependent on actively profilerating erythroid precursor cells for

its replication. This particular tropism is determined by the lack of

a viral DNA polymerase and by a receptor expressed on eythroid

cells, globoside. In addition to the childhood disease erythema

infectiosum, as an immunopathological consequence of infection,

all relevant pathology brought about by B19V is explained by the

property of wiping out erythrocyte precursor cells. A severe break-

down of red cell synthesis or aplastic crisis occurs in cases lacking

recruitment from a resting population, like in sickle cell anemia

and in expanding fetal erythropoiesis. In the fetus, this anemia